Congress failed to reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs last fall. More than a dozen local biotech companies are affected.
Philadelphia biotechs are worried about losing a key source of federal funding for early-stage innovation.
Known as “America’s seed fund,” the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help small… [4217 chars]
Source: The Philadelphia Inquirer | Published: 2026-02-05T10:00:00Z
Credit: The Philadelphia Inquirer
